The fall is largely attributed to the pricing of issue which is comparatively on the higher side and also higher than market expectations given the 80 percent rally registered by the pharma index from March lows, experts feel.

Is Gland Pharma a good buy?

Speaking on the shares that one can buy today Saurabh Jain, AVP — Research at SMC said, "Pharma and IT sector stocks are going to do well in this Covid-hit market. ... I would recommend stock market investors to buy SBI Life and Gland Pharma shares for both short-term and long-term time-frame."

Is Gland Pharma good for long term?

GLAND is progressing well on building a complex product pipeline, backward integration, and gaining market share in commercialized limited-competition products. GLAND has generated Superior return ratios (5 yr avg ROCE: 29%) at minimum leverage and has been steadily growing Asset Turns leading to value unlocking.